Charité Universitaetsmedizin Berlin - Campus Mitte-Hauttumorcentrum Charité (HTCC) ( Site 1302)

Berlin 10115

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) — Running, not enrolling